Timothy L. Cover

Timothy L. Cover's AcademicInfluence.com Rankings

Timothy L. Cover

Philosophy

#6960

World Rank

#10093

Historical Rank

Logic

#4040

World Rank

#5283

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Timothy L. Cover's Degrees

Doctorate Medicine Harvard University

Why Is Timothy L. Cover Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Timothy L. Cover's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. (1995) (1694)
Mosaicism in Vacuolating Cytotoxin Alleles of Helicobacter pylori (1995) (1614)
Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. (2007) (731)
Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production (1993) (718)
Purification and characterization of the vacuolating toxin from Helicobacter pylori. (1992) (709)
Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. (1997) (664)
Helicobacter pylori in health and disease. (2009) (626)
Helicobacter pylori VacA, a paradigm for toxin multifunctionality (2005) (537)
Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity (1990) (473)
Serologic detection of infection with cagA+ Helicobacter pylori strains (1995) (318)
Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. (2003) (317)
Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. (2011) (306)
Helicobacter pylori and gastroduodenal disease. (1992) (279)
Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. (2004) (265)
Helicobacter pylori Persistence: an Overview of Interactions between H. pylori and Host Immune Defenses (2006) (259)
Release of Helicobacter pylori vacuolating cytotoxin by both a specific secretion pathway and budding of outer membrane vesicles. Uptake of released toxin and vesicles by gastric epithelium (1999) (254)
The vacuolating cytotoxin of Helicobacter pylori (1996) (250)
Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin (1991) (247)
Helicobacter pylori strain-specific genotypes and modulation of the gastric epithelial cell cycle. (1999) (227)
Helicobacter pylori and gastric acid: biological and therapeutic implications. (1996) (222)
The oxysterol-binding protein homologue ORP1L interacts with Rab7 and alters functional properties of late endocytic compartments. (2005) (219)
The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH. (1999) (217)
Human and Helicobacter pylori coevolution shapes the risk of gastric disease (2014) (215)
Acid-induced Dissociation of VacA, the Helicobacter pylori Vacuolating Cytotoxin, Reveals Its Pattern of Assembly (1997) (214)
The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. (1998) (211)
Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease (1995) (209)
Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. (1996) (203)
Detection of Helicobacter pylori gene expression in human gastric mucosa (1995) (162)
Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention. (1996) (162)
Binding and internalization of the Helicobacter pylori vacuolating cytotoxin by epithelial cells (1996) (159)
Crystal structure of the Helicobacter pylori vacuolating toxin p55 domain (2007) (158)
High Dietary Salt Intake Exacerbates Helicobacter pylori-Induced Gastric Carcinogenesis (2013) (156)
Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. (2013) (155)
Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells. (2003) (154)
Helicobacter pylori Diversity and Gastric Cancer Risk (2016) (153)
Essential Role of a GXXXG Motif for Membrane Channel Formation by Helicobacter pylori Vacuolating Toxin* (2003) (150)
Association of Helicobacter pylori Vacuolating Toxin (VacA) with Lipid Rafts* (2002) (148)
Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk (2011) (147)
Helicobacter pylori Exploits a Unique Repertoire of Type IV Secretion System Components for Pilus Assembly at the Bacteria-Host Cell Interface (2011) (147)
Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: role of VacA and CagA (1996) (139)
A Dominant Negative Mutant of Helicobacter pyloriVacuolating Toxin (VacA) Inhibits VacA-induced Cell Vacuolation* (1999) (138)
Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori (1994) (136)
VacA from Helicobacter pylori: a hexameric chloride channel (1999) (133)
Regulation of Helicobacter pylori cagA expression in response to salt. (2007) (132)
An Overview of Helicobacter pylori VacA Toxin Biology (2016) (131)
Impaired Autophagy, Defective T Cell Homeostasis, and a Wasting Syndrome in Mice with a T Cell–Specific Deletion of Vps34 (2013) (129)
Simple and Accurate PCR-Based System for Typing Vacuolating Cytotoxin Alleles of Helicobacter pylori (1999) (129)
Functional Plasticity in the Type IV Secretion System of Helicobacter pylori (2013) (127)
Molecular Analysis of Sarcoidosis Tissues for Mycobacterium Species DNA (2002) (126)
A 12-Amino-Acid Segment, Present in Type s2 but Not Type s1 Helicobacter pylori VacA Proteins, Abolishes Cytotoxin Activity and Alters Membrane Channel Formation (2001) (124)
Host response to Helicobacter pylori infection before initiation of the adaptive immune response. (2007) (117)
Potentiation of Helicobacter pylori vacuolating toxin activity by nicotine and other weak bases. (1992) (114)
Helicobacter pylori Vacuolating Cytotoxin Inhibits Activation-Induced Proliferation of Human T and B Lymphocyte Subsets1 (2007) (113)
Epidermal growth factor receptor activation protects gastric epithelial cells from Helicobacter pylori-induced apoptosis. (2009) (111)
Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10 (2014) (110)
Genome sequence analysis of Helicobacter pylori strains associated with gastric ulceration and gastric cancer (2009) (108)
Cellular Vacuolation and Mitochondrial Cytochrome c Release Are Independent Outcomes of Helicobacter pylori Vacuolating Cytotoxin Activity That Are Each Dependent on Membrane Channel Formation* (2003) (106)
Effects of ATPase inhibitors on the response of HeLa cells to Helicobacter pylori vacuolating toxin (1993) (104)
l-Arginine Availability Regulates Inducible Nitric Oxide Synthase-Dependent Host Defense against Helicobacter pylori (2007) (103)
Diet, microbial virulence, and Helicobacter pylori-induced gastric cancer (2013) (99)
In search of the Helicobacter pylori VacA mechanism of action. (2001) (98)
Extracellular Release of Antigenic Proteins byHelicobacter pylori (1998) (98)
Acid activation of Helicobacter pylori vacuolating cytotoxin (VacA) results in toxin internalization by eukaryotic cells (2000) (94)
Heterogeneity in Levels of Vacuolating Cytotoxin Gene (vacA) Transcription among Helicobacter pylori Strains (1998) (93)
Helicobacter pylori VacA Induces Programmed Necrosis in Gastric Epithelial Cells (2011) (92)
Molecular and Structural Analysis of the Helicobacter pylori cag Type IV Secretion System Core Complex (2016) (91)
The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism. (1994) (90)
Downregulated Th17 responses are associated with reduced gastritis in Helicobacter pylori–infected children (2013) (89)
Carboxy-Terminal Proteolytic Processing ofHelicobacter pylori Vacuolating Toxin (2001) (89)
Intercellular Communication in Helicobacter pylori: luxS Is Essential for the Production of an Extracellular Signaling Molecule (2000) (89)
Two Different Families of hopQ Alleles in Helicobacter pylori (2002) (89)
Heterogeneity among Helicobacter pylori Strains in Expression of the Outer Membrane Protein BabA (2004) (88)
Acid‐induced expression of an LPS‐associated gene in Helicobacter pylori (1998) (88)
Characteristics of Helicobacter pylori variants selected for urease deficiency (1992) (87)
Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells. (1998) (87)
Helicobacter pylori Vacuolating Toxin and Gastric Cancer (2017) (85)
Helicobacter pylori infection in japanese patients with adenocarcinoma of the stomach (1993) (81)
Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori. (1992) (80)
Functional Properties of the p33 and p55 Domains of the Helicobacter pylori Vacuolating Cytotoxin* (2005) (80)
The Host Protein Calprotectin Modulates the Helicobacter pylori cag Type IV Secretion System via Zinc Sequestration (2014) (78)
Helicobacter pylori factors associated with disease. (1999) (76)
An RGD Helper Sequence in CagL of Helicobacter pylori Assists in Interactions with Integrins and Injection of CagA (2012) (76)
Characterization of HeLa cell vacuoles induced by Helicobacter pylori broth culture supernatant. (1992) (74)
Cell Vacuolation Induced by the VacA Cytotoxin ofHelicobacter pylori Is Regulated by the Rac1 GTPase* (2000) (74)
Protein-Protein Interactions among Helicobacter pylori Cag Proteins (2006) (74)
Global analysis of Helicobacter pylori gene expression in human gastric mucosa. (2002) (72)
Helicobacter pylori VacA Disrupts Apical Membrane-Cytoskeletal Interactions in Gastric Parietal Cells* (2008) (71)
Clustering and redistribution of late endocytic compartments in response to Helicobacter pylori vacuolating toxin. (2004) (69)
Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States. (2019) (68)
Regulation of Gastric B Cell Recruitment Is Dependent on IL-17 Receptor A Signaling in a Model of Chronic Bacterial Infection1 (2009) (63)
β-Catenin and p120 mediate PPARδ-dependent proliferation induced by Helicobacter pylori in human and rodent epithelia. (2011) (63)
Role of vacuolating cytotoxin in gastritis due to Helicobacter pylori in gnotobiotic piglets (1997) (61)
Analysis of cagA in Helicobacter pylori Strains from Colombian Populations with Contrasting Gastric Cancer Risk Reveals a Biomarker for Disease Severity (2011) (61)
The pathobiology of Campylobacter infections in humans. (1989) (60)
Genes Required for Assembly of Pili Associated with the Helicobacter pylori cag Type IV Secretion System (2014) (59)
Molecular Evolution of the Helicobacter pylori Vacuolating Toxin Gene vacA (2010) (58)
Analysis of Surface-Exposed Outer Membrane Proteins in Helicobacter pylori (2014) (58)
Vacuolating Cytotoxin (vacA) Alleles of Helicobacter pylori Comprise Two Geographically Widespread Types, m1 and m2, and Have Evolved Through Limited Recombination (1999) (57)
Multiple Chromosomal Loci for the babA Gene in Helicobacter pylori (2006) (57)
Amino-Terminal Hydrophobic Region ofHelicobacter pylori Vacuolating Cytotoxin (VacA) Mediates Transmembrane Protein Dimerization (2001) (57)
Helicobacter pylori genotypes, host factors, and gastric mucosal histopathology in peptic ulcer disease. (2001) (55)
Interactions between p-33 and p-55 Domains of the Helicobacter pylori Vacuolating Cytotoxin (VacA)* (2004) (55)
Genome-Wide Transcriptional Profiling in a Histidine Kinase Mutant of Helicobacter pylori Identifies Members of a Regulon (2002) (55)
Non‐invasive Genotyping of Helicobacter pylori cagA, vacA, and hopQ from Asymptomatic Children (2012) (53)
Effects of Helicobacter pylori vacuolating cytotoxin on primary cultures of human gastric epithelial cells. (1996) (52)
Analysis of Helicobacter pylori cagA Promoter Elements Required for Salt-Induced Upregulation of CagA Expression (2012) (52)
Helicobacter pylori vacuolating cytotoxin (VacA) disorganizes the cytoskeletal architecture of gastric epithelial cells. (1999) (52)
Multiple oligomeric states of the Helicobacter pylori vacuolating toxin demonstrated by cryo-electron microscopy. (2002) (52)
Helicobacter pylori HopQ outer membrane protein attenuates bacterial adherence to gastric epithelial cells. (2008) (51)
Peptidomimetic Small Molecules Disrupt Type IV Secretion System Activity in Diverse Bacterial Pathogens (2016) (48)
High resolution structural analysis of Helicobacter pylori VacA toxin oligomers by cryo-negative staining electron microscopy. (2005) (48)
Structure of the Helicobacter pylori Cag type IV secretion system (2019) (48)
Correlation between serological and mucosal inflammatory responses to Helicobacter pylori. (1994) (47)
Analysis of hopQ alleles in East Asian and Western strains of Helicobacter pylori. (2005) (45)
Requirement of Histidine Kinases HP0165 and HP1364 for Acid Resistance in Helicobacter pylori (2006) (45)
Targeting of Helicobacter pylori vacuolating toxin to lipid raft membrane domains analysed by atomic force microscopy. (2004) (44)
Helicobacter pylori culture supernatant interferes with epidermal growth factor-activated signal transduction in human gastric KATO III cells. (1998) (43)
Analysis of Protein Expression Regulated by the Helicobacter pylori ArsRS Two-Component Signal Transduction System (2010) (43)
Structural analysis of the oligomeric states of Helicobacter pylori VacA toxin. (2013) (42)
The Helicobacter pylori Cag Type IV Secretion System. (2020) (42)
Growth Phase Regulation of flaA Expression in Helicobacter pylori Is luxS Dependent (2004) (41)
The Intermediate Region of Helicobacter pylori VacA Is a Determinant of Toxin Potency in a Jurkat T Cell Assay (2012) (40)
Helicobacter pylori VacA Targets Myeloid Cells in the Gastric Lamina Propria To Promote Peripherally Induced Regulatory T-Cell Differentiation and Persistent Infection (2019) (39)
Functional Analysis of Neutralizing Antibodies against Clostridium perfringens Epsilon-Toxin (2007) (39)
Helicobacter pylori cytotoxin induces vacuolation of primary human mucosal epithelial cells. (1996) (39)
Helicobacter pylori VacA Subdomain Required for Intracellular Toxin Activity and Assembly of Functional Oligomeric Complexes (2008) (38)
PIKfyve Kinase and SKD1 AAA ATPase Define Distinct Endocytic Compartments (2002) (37)
Mutational Analysis of the vacA Promoter Provides Insight into Gene Transcription in Helicobacter pylori (1999) (37)
Promoter analysis of Helicobacter pylori genes with enhanced expression at low pH (2003) (36)
Kinetics and Mechanisms of Extracellular Protein Release by Helicobacter pylori (1999) (35)
CHAPTER 11 – H. pylori Pathogenesis (2001) (35)
In Situ Molecular Architecture of the Helicobacter pylori Cag Type IV Secretion System (2019) (34)
In Helicobacter pylori auto-inducer-2, but not LuxS/MccAB catalysed reverse transsulphuration, regulates motility through modulation of flagellar gene transcription (2010) (33)
Effects of Helicobacter pylori on intracellular Ca2+ signaling in normal human gastric mucous epithelial cells. (2003) (33)
Flagellar Localization of a Helicobacter pylori Autotransporter Protein (2013) (33)
Reconstitution of Helicobacter pylori VacA toxin from purified components. (2010) (33)
Alterations in Helicobacter pylori Triggered by Contact with Gastric Epithelial Cells (2012) (32)
Role of Connexin 43 in Helicobacter pylori VacA-Induced Cell Death (2013) (31)
Resistance of Primary Murine CD4+ T Cells to Helicobacter pylori Vacuolating Cytotoxin (2006) (31)
Detection of Anti-VacA Antibody Responses in Serum and Gastric Juice Samples Using Type s1/m1 and s2/m2 Helicobacter pylori VacA Antigens (1999) (31)
Genetic diversity in Helicobacter pylori. (1997) (31)
Alteration of the Helicobacter pylori membrane proteome in response to changes in environmental salt concentration (2015) (30)
Transmaternal Helicobacter pylori exposure reduces allergic airway inflammation in offspring through regulatory T cells (2019) (30)
Analysis of F1F0-ATPase from Helicobacter pylori (1997) (29)
Comparative Genomic Analysis of East Asian and Non-Asian Helicobacter pylori Strains Identifies Rapidly Evolving Genes (2013) (28)
Helicobacter pylori and mitogen-activated protein kinases mediate activator protein-1 (AP-1) subcomponent protein expression and DNA-binding activity in gastric epithelial cells. (2008) (28)
Recovery from lactacidosis‐induced glial cell swelling with the aid of exogenous anion channels (2003) (26)
High-Salt Conditions Alter Transcription of Helicobacter pylori Genes Encoding Outer Membrane Proteins (2017) (26)
Pan-genomic analyses identify key Helicobacter pylori pathogenic loci modified by carcinogenic host microenvironments (2017) (25)
Regulation of Helicobacter pylori Virulence Within the Context of Iron Deficiency. (2015) (25)
Quantitative Effect of luxS Gene Inactivation on the Fitness of Helicobacter pylori (2006) (24)
An intracellular target for Helicobacter pylori vacuolating toxin. (1998) (23)
Antigenic Diversity among Helicobacter pyloriVacuolating Toxins (2001) (22)
The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism. (1994) (22)
Helicobacter pylori and its secreted immunomodulator VacA protect against anaphylaxis in experimental models of food allergy (2017) (22)
LRRC8 family proteins within lysosomes regulate cellular osmoregulation and enhance cell survival to multiple physiological stresses (2020) (21)
Growth phase-dependent composition of the Helicobacter pylori exoproteome. (2016) (21)
J-Western Forms of Helicobacter pylori cagA Constitute a Distinct Phylogenetic Group with a Widespread Geographic Distribution (2012) (19)
Oxidative Phosphorylation System in Gastric Carcinomas and Gastritis (2017) (19)
Dietary Composition Influences Incidence of Helicobacter pylori-Induced Iron Deficiency Anemia and Gastric Ulceration (2016) (18)
Commentary: Helicobacter pylori transmission, host factors, and bacterial factors. (1997) (18)
H. pylori stimulates gastrin release from canine antral cells in primary culture. (1998) (18)
Genomic Comparison of cag Pathogenicity Island (PAI)-Positive and -Negative Helicobacter pylori Strains: Identification of Novel Markers for cag PAI-Positive Strains (2005) (18)
Helicobacter pylori Adaptation In Vivo in Response to a High-Salt Diet (2015) (18)
Expression of Helicobacter pylori Vacuolating Toxin in Escherichia coli (2003) (18)
Antibody Responses to Streptococcus Gallolyticus Subspecies Gallolyticus Proteins in a Large Prospective Colorectal Cancer Cohort Consortium (2018) (17)
Analysis of a β-helical region in the p55 domain of Helicobacter pylori vacuolating toxin (2010) (17)
Helicobacter pylori VacA Toxin Inhibits Human Immunodeficiency Virus Infection of Primary Human T Cells (2006) (17)
Cryo-EM reveals species-specific components within the Helicobacter pylori Cag type IV secretion system core complex (2020) (16)
Cryo-EM Analysis Reveals Structural Basis of Helicobacter pylori VacA Toxin Oligomerization. (2019) (16)
Helicobacter pylori and Other Gastric Helicobacter Species (2015) (16)
A Nonoligomerizing Mutant Form of Helicobacter pylori VacA Allows Structural Analysis of the p33 Domain (2016) (16)
Mimicry of a host anion channel by a Helicobacter pylori pore-forming toxin. (2005) (15)
Mapping of a Domain Required for Protein-Protein Interactions and Inhibitory Activity of a Helicobacter pylori Dominant-Negative VacA Mutant Protein (2006) (15)
Bacterial Energetic Requirements for Helicobacter pylori Cag Type IV Secretion System-Dependent Alterations in Gastric Epithelial Cells (2019) (15)
Perspectives on methodology for in vitro culture of Helicobacter pylori. (2012) (15)
Intracellular Degradation of Helicobacter pylori VacA Toxin as a Determinant of Gastric Epithelial Cell Viability (2019) (15)
Structural Analysis of the DNA-binding Domain of the Helicobacter pylori Response Regulator ArsR* (2009) (15)
Structural organization of membrane‐inserted hexamers formed by Helicobacter pylori VacA toxin (2016) (14)
Colistin-Functionalized Nanoparticles for the Rapid Capture of Acinetobacter baumannii. (2016) (14)
Carcinogenic Helicobacter pylori Strains Selectively Dysregulate the In Vivo Gastric Proteome, Which May Be Associated with Stomach Cancer Progression* (2018) (14)
Genome Sequences of Three hpAfrica2 Strains of Helicobacter pylori (2013) (13)
Determinants of Raft Partitioning of the Helicobacter pylori Pore-Forming Toxin VacA (2018) (13)
Racial Differences in Helicobacter pylori CagA Sero-prevalence in a Consortium of Adult Cohorts in the United States (2020) (11)
Control of gene expression in Helicobacter pylori using the Tet repressor. (2013) (11)
Temporal Control of the Helicobacter pylori Cag Type IV Secretion System in a Mongolian Gerbil Model of Gastric Carcinogenesis (2020) (11)
Role of Helicobacter pylori outer membrane proteins in gastroduodenal disease. (2006) (11)
Serological Assays for Identification of Human Gastric Colonization by Helicobacter pylori Strains Expressing VacA m1 or m2 (2007) (10)
Lipoprotein Processing and Sorting in Helicobacter pylori (2020) (10)
Evaluation of cytotoxic activity in fecal filtrates from patients with Campylobacter jejuni or Campylobacter coli enteritis. (1990) (9)
Role of Helicobacter pylori CagL in modulating gastrin expression (2012) (9)
Magnetic Extraction of Acinetobacter baumannii Using Colistin-Functionalized γ-Fe2O3/Au Core/Shell Composite Nanoclusters. (2017) (9)
Random Mutagenesis of Helicobacter pylori vacA To Identify Amino Acids Essential for Vacuolating Cytotoxic Activity (2006) (8)
Over The Fence (1997) (8)
Effect of environmental salt concentration on the Helicobacter pylori exoproteome. (2019) (8)
Dynamic Computational Model of Symptomatic Bacteremia to Inform Bacterial Separation Treatment Requirements (2016) (8)
Helicobacter pylori genetic diversification in the Mongolian gerbil model (2018) (8)
Molecular architecture of bacterial type IV secretion systems (2022) (8)
Delineation of the pH-Responsive Regulon Controlled by the Helicobacter pylori ArsRS Two-Component System (2021) (6)
Functional Properties of Helicobacter pylori VacA Toxin m1 and m2 Variants (2020) (6)
Genetic signatures for Helicobacter pylori strains of West African origin (2017) (6)
Role of a Stem-Loop Structure in Helicobacter pylori cagA Transcript Stability (2018) (6)
Vibrio cholerae wound infection acquired in Colorado. (1989) (4)
Adenocarcinoma of the Stomach Associated with an Increased Risk of Developing Is cagA Strains Possessing Helicobacter pylori Infection with Updated (2006) (4)
Carcinogenic Helicobacter pylori Strains Selectively Dysregulate the In Vivo Gastric Proteome, Which May Be Associated with Stomach Cancer Progression. (2019) (3)
Beta2 integrin mediates entry of a bacterial toxin into T lymphocytes. (2008) (3)
Biotinylation and Purification of Surface-exposed Helicobacter pylori Proteins. (2015) (3)
Association of Combined Sero-Positivity to Helicobacter pylori and Streptococcus gallolyticus with Risk of Colorectal Cancer (2020) (3)
An infection-induced oxidation site regulates legumain processing and tumor growth (2022) (3)
119 European Phylogenetic Origin of Helicobacter pylori Strains as a Risk Factor for Premalignant Gastric Lesions in Colombia (2010) (3)
Helicobacter pylori-induced TLR9 Activation and Injury are Associated with the Virulence-Associated Adhesin HopQ. (2020) (2)
Enhanced Fitness of a Helicobacter pylori babA Mutant in a Murine Model (2021) (2)
Supporting data for analysis of the Helicobacter pylori exoproteome (2015) (2)
CHAPTER 24 – Helicobacter pylori vacuolating toxin (2006) (2)
Detection ofHelicobacter pyloriGene Expression in Human Gastric Mucosa (1995) (1)
Helicobacter pylori vacA S1A strains attenuate apoptosis in vitro and in vivo through a toxin-independent mechanism (1998) (1)
Loss of Corpus-Specific Lipids in Helicobacter pylori-Induced Atrophic Gastritis (2021) (1)
Determinants of Helicobacter pylori vacuolating cytotoxin production analysed by construction of vacA hybrids and by site-directed mutagenesis* (1998) (1)
Positive Selection of Mutations in the Helicobacter pylori katA 5′ Untranslated Region in a Mongolian Gerbil Model of Gastric Disease (2022) (1)
Prediagnostic Antibody Responses to Fusobacterium nucleatum Proteins Are Not Associated with Risk of Colorectal Cancer in a Large U.S. Consortium (2021) (1)
Mo1725 – Helicobacter Pylori Infection Does Not Modify the Protective Effect of Regular Aspirin Use on Colorectal Cancer Risk in a Population of US Adults (2019) (1)
Reduced Gastric TH17 Response in Children is Associated With Decreased Helicobacter pylori-Induced Gastritis (2011) (1)
Epithelial Coculture and l-Lactate Promote Growth of Helicobacter cinaedi under H2-Free Aerobic Conditions (2016) (1)
Helicobacter pylori in gnotobiotic piglets . Role of vacuolating cytotoxin in gastritis due to (1997) (1)
Helicobacter pylori Vacuolating Toxin (2016) (1)
Functional Properties of Oligomeric and Monomeric Forms of Helicobacter pylori VacA Toxin (2021) (1)
pylori stimulates gastrin release from canine antral cells in primary culture (1998) (1)
Tracking bacterial effector protein delivery into host cells (2021) (0)
Helicobacter pylori vacuolating cytotoxin (VacA) inhibits tubulovesicle fusion-possible mechanism for the inhibition of acid secretion in isolated gastric glands (2001) (0)
Human T and B Lymphocyte Subsets Inhibits Activation-Induced Proliferation of Vacuolating Cytotoxin Helicobacter pylori (2007) (0)
Faculty Opinions recommendation of Helicobacter pylori outer membrane protein HopQ identified as a novel T4SS-associated virulence factor. (2013) (0)
Helicobacterpylori and mitogen-activated protein kinases mediate activator protein-1 (AP-1) subcomponent protein expression and DNA-binding activity in gastric epithelial cells (2008) (0)
H. pylori stimulates gastrin release from canine antral cells in primary culture. (1998) (0)
Structural Characterization of the Helicobacter Pylori VacA Toxin by Single Particle Em and X-Ray Crystallography (2013) (0)
Proteomic Analysis of the Helicobacter pylori ArsRS Regulon by DIGE-MS (2010) (0)
Faculty Opinions recommendation of Quantitative analysis of CagA type IV secretion by Helicobacter pylori reveals substrate recognition and translocation requirements. (2016) (0)
Helicobacter pylori vacuolating cytotoxin A exploits human endosomes for intracellular activation (2022) (0)
Cryo-EM Structure of the Helicobacter pylori OMC (2020) (0)
Carcinogenic Host Microenvironments Target and Modify Key Pathogenic Loci within Helicobacter Pylori (2017) (0)
Author response: Structure of the Helicobacter pylori Cag type IV secretion system (2019) (0)
Characteristics ofHelicobacterpylori Variants Selected forUrease Deficiency (1992) (0)
Identification of an Essential LolD-Like Protein in Helicobacter pylori (2023) (0)
Faculty Opinions recommendation of Helicobacter pylori Adapts to Chronic Infection and Gastric Disease via pH-Responsive BabA-Mediated Adherence. (2017) (0)
Structural Analysis of Helicobacter pylori VacA's Channel in Membrane (2022) (0)
High Resolution Electron Microscopy Analysis of the Helicobacter pylori Cag Type IV Secretion System (2013) (0)
Su1264 – Helicobacter Pylori Antibody Prevalence by Year of Birth and Demographic Factors in a Consortium of US Adults (2019) (0)
PolyAla Model of the PRC from the Type 4 Secretion System of H. pylori (2019) (0)
Structure of CagY from a cryo-EM reconstruction of a T4SS (2019) (0)
Acknowledgment to reviewers (2018) (0)
Characterizing the Intracellular Trafficking of Helicobacter pylori VacA (2017) (0)
Cryo-EM Structure of CagX and CagY within the Helicobacter pylori PR (2020) (0)
Host response to Helicobacterpylori infection before initiation of the adaptive immune response (2007) (0)
PolyAla Model of OMCC I-Layer (2019) (0)
Role of IL-17 receptor alpha (IL-17Rα) signaling in Helicobacter pylori-host interactions (129.7) (2009) (0)
a Model of Chronic Bacterial Infection Dependent on IL-17 Receptor A Signaling in Regulation of Gastric B Cell Recruitment Is (2009) (0)
ArsR DNA Binding Domain (2008) (0)
Treatment with Helicobacter pylori-derived VacA attenuates allergic airway disease (2023) (0)
Sa1864 Iron Deficiency Reveals an Aberrant Morphology Phenotype Exhibited by CagA-Deficient Helicobacter pylori Strains (2013) (0)
Structure of CagT from a cryo-EM reconstruction of a T4SS (2019) (0)
Helicobacter pylori HopQoutermembraneproteinattenuates bacterial adherence togastric epithelial cells (2008) (0)
Structural Analysis of the Helicobacter pylori pore forming toxin, VacA (2017) (0)
617 Iron Deficiency Amplifies the Pathogenic Potential of Carcinogenic cag+ Helicobacter pylori via Enhancing Function of the cag Type IV Secretion System (2012) (0)
Analysis of H. pylori-induced intracellular Ca2+ signaling in human gastric mucous epithelial cells (2001) (0)
An infection-activated redox switch promotes tumor growth (2021) (0)
Cryo-EM Structure of CagX and CagY within the dCag3 Helicobacter pylori PR (2020) (0)
An antigenic fragment of the tagA gene and methods for the detection of predisposition to peptic ulcer and gastric carcinoma (1995) (0)
1077 - Helicobacter Pylori Cag+ Strains Induce Alterations in the In Vivo Epithelial Proteome that are Associated with Progression of Gastric Carcinogenesis (2018) (0)
Regulation of Helicobacter pylori Urease and Acetone Carboxylase Genes by Nitric Oxide and the CrdRS Two-Component System (2023) (0)
Cryo-EM Structure of the Helicobacter pylori dCag3 OMC (2020) (0)
This information is current as Specific Deletion of Vps 34 − Mice with a T Cell Homeostasis , and a Wasting Syndrome in Impaired Autophagy , Defective T Cell (2013) (0)
Structural Analysis of Helicobacter pylori VacA Reveals Insights into Oligomerization (2019) (0)
Cryo-EM structure of Helicobacter pylori VacA hexamer (2019) (0)
Helicobacter Pylori Derived Vacuolating Cytotoxin A (VacA) Modulates the Allergen Specific Interaction of Dendritic Cells with T Cells (2022) (0)
Tu1287 - Discovery-Driven Metabolomics Identifies Novel Microbial Metabolites Altered in Helicobacter Pylori Strains Conditioned to In Vivo Carcinogenic Environments (2018) (0)
The Helicobacter pylori vacuolating cytotoxin, VacA, induces both epithelial cell cytoskeletal disruption and vacuolation, but these phenomena are not interdependent (2000) (0)
PolyAla Model of the O-layer from the Type 4 Secretion System of H. pylori (2019) (0)
Acid-activation of Helicobacter pylori vacuolating cytotoxin is required for toxin internalization by eukaryotic cells (2000) (0)
Structure of theHelicobacter pyloriCag Type IV secretion system. (2019) (0)
Role of IL-17 receptor alpha (IL-17R{alpha}) signaling in Helicobacter pylori-host interactions (2009) (0)
A Positively Selected fur-R88H Mutation Enhances Helicobacter pylori Fitness in a High-Salt Environment and Alters Fur-Dependent Regulation of Gene Expression (2023) (0)
Inertial-based Fluidic Platform for Rapid Isolation of Blood-borne Pathogens. (2021) (0)
Structure of CagX from a cryo-EM reconstruction of a T4SS (2019) (0)
Research LetterEvaluation of cytotoxic activity in fecal filtrates from patients with Campylobacter jejuni or Campylobacter coli enteritis (1990) (0)
Determining a Sub-nanometer Resolution Structure of a Helicobacter pylori VacA Toxin Oligomer (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Timothy L. Cover?

Timothy L. Cover is affiliated with the following schools:

Ohio State University
University of Pavia
Vanderbilt University
University of California, San Francisco
Massachusetts General Hospital
Harvard University